Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Neurology

Results: 1-25/2467

Authors: Dalakas, MC
Citation: Mc. Dalakas, The use of intravenous immunoglobulin for neurologic diseases, NEUROLOGY, 51(6), 1998, pp. S1-S1

Authors: Dalakas, MC
Citation: Mc. Dalakas, Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases, NEUROLOGY, 51(6), 1998, pp. S2-S8

Authors: Sater, RA Rostami, AM
Citation: Ra. Sater et Am. Rostami, Treatment of Guillain-Barre syndrome with intravenous immunoglobulin, NEUROLOGY, 51(6), 1998, pp. S9-S15

Authors: Hahn, AF
Citation: Af. Hahn, Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin, NEUROLOGY, 51(6), 1998, pp. S16-S21

Authors: Pestronk, A
Citation: A. Pestronk, Multifocal motor neuropathy: Diagnosis and treatment, NEUROLOGY, 51(6), 1998, pp. S22-S24

Authors: Lisak, RP
Citation: Rp. Lisak, Intravenous immunoglobulins in multiple sclerosis, NEUROLOGY, 51(6), 1998, pp. S25-S29

Authors: Howard, JF
Citation: Jf. Howard, Intravenous immunoglobulin for the treatment of acquired myasthenia gravis, NEUROLOGY, 51(6), 1998, pp. S30-S36

Authors: Dalakas, MC
Citation: Mc. Dalakas, Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis, NEUROLOGY, 51(6), 1998, pp. S37-S45

Authors: Joynt, RJ
Citation: Rj. Joynt, Medical and social consequences of homophony, NEUROLOGY, 51(6), 1998, pp. 24A-24A

Authors: Zeviani, M Moraes, CT DiMauro, S Nakase, H Bonilla, E Schon, EA Rowland, LP
Citation: M. Zeviani et al., Deletions of mitochondrial DNA in Kearns-Sayre syndrome (Reprinted from Neurology, vol 38, pg 1339-1346, 1988), NEUROLOGY, 51(6), 1998, pp. 1339-1346

Authors: Zeviani, M Moraes, CT DiMauro, S Nakase, H Bonilla, E Schon, EA Rowland, LP
Citation: M. Zeviani et al., Deletions of mitochondrial DNA in Kearns-Sayre syndrome, NEUROLOGY, 51(6), 1998, pp. 1525-1525

Authors: Kieburtz, K
Citation: K. Kieburtz, Avoiding conflicts of interest - Responsibilities of authors, reviewers, and editors, NEUROLOGY, 51(6), 1998, pp. 1527-1528

Authors: D'Esposito, M
Citation: M. D'Esposito, Serotonin neurotoxicity - Implications for cognitive neuroscience and neurology, NEUROLOGY, 51(6), 1998, pp. 1529-1530

Authors: Cranford, R
Citation: R. Cranford, Even the dead are not terminally ill anymore, NEUROLOGY, 51(6), 1998, pp. 1530-1531

Authors: Bolla, KI McCann, UD Ricaurte, GA
Citation: Ki. Bolla et al., Memory impairment in abstinent MDMA ("Ecstasy") users, NEUROLOGY, 51(6), 1998, pp. 1532-1537

Authors: Shewmon, DA
Citation: Da. Shewmon, Chronic "brain death" - Meta-analysis and conceptual consequences, NEUROLOGY, 51(6), 1998, pp. 1538-1545

Authors: Neary, D Snowden, JS Gustafson, L Passant, U Stuss, D Black, S Freedman, M Kertesz, A Robert, PH Albert, M Boone, K Miller, BL Cummings, J Benson, DF
Citation: D. Neary et al., Frontotemporal lobar degeneration - A consensus on clinical diagnostic criteria, NEUROLOGY, 51(6), 1998, pp. 1546-1554

Authors: Mueller, EA Moore, MM Kerr, DCR Sexton, G Camicioli, RM Howieson, DB Quinn, JF Kaye, JA
Citation: Ea. Mueller et al., Brain volume preserved in healthy elderly through the eleventh decade, NEUROLOGY, 51(6), 1998, pp. 1555-1562

Authors: Lovell, MA Xie, C Markesbery, WR
Citation: Ma. Lovell et al., Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease, NEUROLOGY, 51(6), 1998, pp. 1562-1566

Authors: Samuel, M Williams, SCR Leigh, PN Simmons, A Chakraborti, S Andrew, CM Friston, KJ Goldstein, LH Brooks, DJ
Citation: M. Samuel et al., Exploring the temporal nature of hemodynamic responses of cortical motor areas using functional MRI, NEUROLOGY, 51(6), 1998, pp. 1567-1575

Authors: Deckel, AW Cohen, D Duckrow, R
Citation: Aw. Deckel et al., Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease, NEUROLOGY, 51(6), 1998, pp. 1576-1583

Authors: Ziv, I Avraham, M Michaelov, Y Djaldetti, R Dressler, R Zoldan, J Melamed, E
Citation: I. Ziv et al., Enhanced fatigue during motor performance in patients with Parkinson's disease, NEUROLOGY, 51(6), 1998, pp. 1583-1586

Authors: Agundez, JAG Jimenez-Jimenez, FJ Luengo, A Molina, JA Orti-Pareja, M Vazquez, A Ramos, F Duarte, J Coria, F Ladero, JM Alvarez-Cermeno, JC Benitez, J
Citation: Jag. Agundez et al., Slow allotypic variants of the NAT2 gene and susceptibility to early-onsetParkinson's disease, NEUROLOGY, 51(6), 1998, pp. 1587-1592

Authors: Baker, KK Ramig, LO Luschei, ES Smith, ME
Citation: Kk. Baker et al., Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging, NEUROLOGY, 51(6), 1998, pp. 1592-1598

Authors: Earley, CJ Yaffee, JB Allen, RP
Citation: Cj. Earley et al., Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome, NEUROLOGY, 51(6), 1998, pp. 1599-1602
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>